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ABSTRACT 
Objectives: 
Global vaccination policy advocates for identifying and targeting groups who are under-
served by vaccination to increase equity and uptake.  We investigated whether birth 
weight and other factors are determinants of neonatal BCG vaccination, in order to 
identify infants under-served by vaccination. 
 
Methods: 
We used logistic regression to calculate adjusted odds ratios (AOR) for the association 
between birth weight (categorised as non-low birth weight (NLBW) (≥2.50kg) and low 
birth weight (LBW) (2-2.49kg, 1.50-1.99kg and <1.50kg) and non-vaccination with BCG at 
the end of the neonatal period (0-27 days). We assessed whether this association varied 
by place of delivery and infant illness. We calculated how BCG timing and uptake would 
improve by ensuring the vaccination of all facility-born infants prior to discharge. 
 
Results: 
There was a strong dose response relationship between LBW and not receiving BCG in 
the neonatal period (p-trend<0.0001). Infants weighing 1.50-1.99kg had odds of non-
vaccination 1.6 times (AOR=1.64; 95%CI:1.30-2.08), and those weighing <1.50kg 2.4 
times (AOR=2.42; 95%CI:1.50-3.88) those of NLBW infants. Other determinants included 
place of delivery, distance to the health facility and socioeconomic status. Neither place 
of delivery nor infant illness modified the association between birth weight and 
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vaccination (p-interaction all >0.19). Facility-born infants were vaccinated at a mean of 6 
days, suggesting they were not vaccinated in the facility at birth but were referred for 
vaccination.  
 
Conclusions 
LBW is a risk factor for neonatal vaccination, even for facility-born infants. Ensuring 
vaccination at facility births would substantively improve timing and equitable BCG 
vaccination.  
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INTRODUCTION  
Approximately 3 in 10 deaths among children aged 1-59 months are vaccine 
preventable,1 and one in five infants is not fully vaccinated by age 52 weeks. Substantive 
socio-demographic inequities in vaccination remain.2 Many infants are vaccinated late.3 
4 The latest global vaccination policy highlights the need to identify and target those 
under-served by vaccination, in order to increase equity and uptake.2  
 
Using data from a large prospective population-based trial of neonatal vitamin A 
supplementation in Kintampo in rural Ghana (Neovita), we previously reported that LBW 
infants are more likely to be delayed in their DTP1 and DTP3 vaccination.5 For 
postneonatal vaccines, the onus is on the care-taker to bring the infant for vaccination 
at scheduled times. Any vaccination delay may be partly due to care-taker hesitancy to 
bring infants for vaccination, possibly due to their fragility or illness.6 This may not be 
the case for neonatal vaccinations, as the large proportion of facility-born infants 
automatically have opportunities for vaccination.  Consequently, vaccine determinants 
may differ in these periods. In an effort to identify further those under-served by 
vaccination, we investigated birth weight and other factors as determinants of neonatal 
vaccination.  
 
In countries with a high prevalence of tuberculosis, the World Health Organisation 
(WHO) recommends “BCG be given to all healthy neonates, or as soon as possible after 
birth”.7 In addition to BCG, in Ghana, a birth dose of polio (OPVB) is recommended at a 
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maximum age of two weeks,8 as part of a four dose schedule. Hepatitis B is not 
recommended in the schedule. The WHO recommends BCG vaccination by intradermal 
injection to the arm,7 whereas OPVB is given orally.9 We selected BCG as an indicator for 
neonatal vaccination due to its longer recommended window for administration 
(throughout the neonatal period), and on the basis that any hesitancy relating to the 
vaccination of fragile infants would be more evident for injected vaccines. 
 
Low birth weight is not a contraindication to BCG vaccination. 7 The WHO advises that 
infants should receive all due vaccines prior to discharge from health facilities.10 
Therefore, infants born in health facilities should be vaccinated prior to discharge home. 
 
Infant illness has been cited as a reason for non-vaccination by both caregivers and 
vaccine-providers.6 Given this, and the opportunities for vaccination associated with 
being born in a facility, as secondary objectives we investigated whether the association 
between birth weight and neonatal BCG vaccination varied by place of delivery and 
infant illness.  
 
MATERIALS AND METHODS  
Neovita was undertaken at the Kintampo Health Research Centre (KHRC) in rural Ghana. 
Trial methods have been described in detail elsewhere.11 12 
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In Ghana, neonatal vaccines are given either at the health facility following delivery, or 
at child health clinics in health facilities or Community Health Planning System (CHPS) 
compounds in the community. Monthly mobile outreach clinics target areas lacking 
health facilities or CHPS compounds. Following vaccination, the vaccine provider records 
(on a vaccination card, or less commonly, in the mother’s antenatal card) the 
administrated vaccine, the batch-number, date, and clinic name.  
 
Infants who were up to three days of age at screening, who could suckle or feed, and 
who were staying in the study area for at least six months after enrolment were 
included in the trial.  
 
Trained field workers used a prospective surveillance system (that monitored registered 
women aged 15-49 years for pregnancies and deliveries) to ascertain all births in the 
study area between August 2010 and November 2011. They enrolled eligible infants of 
consenting mothers in the trial and weighed them using calibrated electronic (38%) or 
spring (62%) scales. They recorded birth weights to the nearest 0.1kg (electronic scales) 
or 0.2kg (spring scales). All but five infants (0.2%) were weighed within 72 hours of 
delivery. At enrolment, field workers collected data on infant, maternal and household 
characteristics. Data on vaccination status (written record and maternal recall) were 
collected at monthly follow-up visits.   
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Infants were categorised as a) vaccinated, known vaccination date (if they had a 
plausible vaccination date on their vaccination card); b) vaccinated, unknown 
vaccination date (if they had an unknown or implausible date on their card); and c) 
unvaccinated (if either i) their card was viewed and had no evidence of vaccination, or ii) 
their card was not viewed (possibly because they did not have a card) but their 
caretaker consistently reported that they had never been vaccinated). In addition, 
infants whose card was never viewed and whose mothers reported they were 
vaccinated, but did not report which vaccine they received, were categorised as 
vaccination status unknown, as were those infants never seen in follow-up, with no 
information on their vaccination status. 
 
We categorised infants as either non-low birth weight (NLBW) (weighing ≥2.50kg) or low 
birth weight (LBW) (2.00-2.49kg, 1.50-1.99kg, and <1.50kg). Neonatal illness was a 
health facility admission in the neonatal period (0-27 days of age). 
 
Infants with known vaccination status, in follow-up at the end of the neonatal period, 
and having complete covariate data were eligible for inclusion in the analyses.  
 
Analytical methods 
We conducted all analyses using STATA 14.1 (STATACORP, 2015). As neonatal BCG 
vaccination is a frequent event, we calculated adjusted odds ratios (AOR) for the less 
frequent outcome of non-vaccination (rather than for vaccination) using multivariable 
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logistic regression. The resulting AORs for this less frequent outcome thus approximated 
more closely to risk or rate ratios. Model building was informed by a hierarchical 
framework5 of the determinants of vaccination identified a priori.3 4 13 14 We initially fit a 
model comprising distal determinants (religion, ethnicity, socioeconomic status, maternal 
occupation, maternal education, vaccine due in wet season, infant sex); then added 
intermediate determinants (maternal age/ family size, maternal illness in the year 
before delivery, distance to the nearest health facility, place of delivery, multiple birth), 
followed by birth weight, and finally infant illness, a possible mediator of the association 
between birth weight and vaccination. We used likelihood ratio tests and 95% 
confidence intervals (95%CI) to assess statistical associations between each explanatory 
variable and vaccination.  
 
We fitted interaction terms of birth weight and i) place of delivery, and ii) neonatal 
illness to the final model to assess whether either of these modified the association 
between birth weight and vaccination.  
 
For all infants, irrespective of place of birth, we calculated BCG uptake rates at the end 
of the neonatal period and at 8, 12 and 52 weeks of age, stratified by birth weight, to 
examine variation by time since the due date. To assess how ensuring vaccination of 
facility-born infants prior to discharge would affect vaccination, we calculated 
‘theoretical’ proportions vaccinated by assigning these infants as vaccinated in the 
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neonatal period. We calculated the proportional increase in vaccination by dividing the 
theoretical proportion by the actual proportion for each time-period.  
 
The ethics committees of the World Health Organisation (WHO), the London School of 
Hygiene & Tropical Medicine (LSHTM) and the KHRC granted approval for the Neovita 
trial. No additional ethics approval was needed for this study. 
 
The Bill and Melinda Gates Foundation funded the Neovita trial. 
 
RESULTS  
Of 22955 infants enrolled in Neovita, 22217 (96.8%) were included in the analyses. 
Among 738 excluded, 362 were BCG vaccination status unknown, 242 were BCG 
vaccinated with an unknown date, 88 were lost-to-follow up in the neonatal period, and 
46 were missing covariate data. Of those excluded, 275 died in the neonatal period. 
Table 1 shows that excluded infants were more likely to have LBW, to live further from a 
health facility, to be a multiple birth and to have poorer mothers. 
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Table 1: Baseline characteristics of infants included in the analyses of determinants of neonatal 
BCG vaccination.  
 Excluded Included 
Variable Total=738 Total = 22217 
Distal Determinants   
Religion of head of household 
Christian 
Muslim 
None/Traditional/Other 
 
471 (63.8) 
201 (27.2) 
66 (8.9) 
 
15508 (69.8) 
5310 (23.9) 
1399 (6.3) 
Ethnicity 
Akan 
Non-Akan 
 
317 (43.0) 
421 (57.0) 
 
10376 (46.7) 
11841 (53.3) 
Socioeconomic status 
1 (poorest) 
2 
3 
4  
5(richest) 
Missing Values 
 
185 (25.1) 
174 (23.6) 
150 (20.3) 
125 (16.9) 
103 (14.0) 
1 (0. 1) 
 
4325 (19.5) 
4376 (19.7) 
4433 (20.0) 
4519 (20.3) 
4564 (20.5) 
Maternal occupation 
Gov/Private/ Other 
Self-employed 
Farming 
Does not work 
 
31 (4.2) 
232 (31.4) 
251 (34.0) 
224 (30.4) 
 
1194 (5.4) 
8714 (39.2) 
6420 (28.9) 
5889 (26.5) 
Maternal education 
None 
Primary school 
Secondary / tertiary 
Missing Values 
 
264 (35.8) 
138 (18.7) 
322 (43.6) 
14 (1.9) 
 
6863 (30.9) 
4098 (18.5) 
11256 (50.7) 
Vaccine due in wet season 461 (62.5) 14494 (65.2) 
Sex, Female  340 (46.1) 10966 (49.4) 
Intermediate Determinants   
Maternal age / Family size 
<20 years 
20-29; 1-3 children 
20-29; ≥4 children 
≥30; 1-3 children 
≥30; ≥4 children 
Missing Values 
 
114 (15.4) 
263 (35.6) 
120 (16.3) 
29 (3.9) 
182 (24.7) 
30 (4.1) 
 
2531 (11.3) 
7815 (35.2) 
3843 (17.3) 
1108 (5.0) 
6920 (31.2) 
Maternal illness in year before delivery 32 (4.3) 1091 (4.9) 
Distance  
<1.00km 
1.00-4.99km 
>=5.00km 
Missing Values 
 
409 (55.5) 
152 (20.6) 
174 (23.6) 
2 (0.3) 
 
13471 (60.6) 
5133 (23.1) 
3613 (16.3) 
Facility delivery 517 (70.1) 17064 (76.8) 
Multiple birth 52 (7.1) 795 (3.6) 
Proximal Variables   
Birth weight 
>=2.5kg 
2.00-2.49kg 
1.50-1.99kg 
<1.50kg 
Missing Values 
 
520 (70.5) 
121 (16.4) 
59 (8.0) 
36 (4.8) 
2 (0.3) 
 
18841 (84.8) 
2910 (13.1) 
385 (1.7) 
81 (0.4) 
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Mediating Variables   
Neonatal illness 31 (4.2) 426 (1.9) 
 
Infants were BCG vaccinated at a median of 8 days; 77% were vaccinated by the end of 
the neonatal period. Uptake decreased with declining birth weight, and was lowest 
(60%) among infants weighing <1.50kg. There was a strong dose-response relationship 
between LBW and the odds of non-vaccination in the neonatal period (p-trend<0.0001), 
after adjustment for other variables (Table 2). Infants weighing 1.50-1.99kg (AOR=1.64; 
95%CI:1.30-2.08) and those weighing <1.50kg (AOR=2.42; 95%CI:1.50-3.88) had odds of 
non-vaccination 1.6 times and 2.4 times those of NLBW infants.  
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Table 2: Determinants of non-vaccination with BCG in the neonatal period 
  
Not Vaccinated 
/ Total  
Proportion not 
vaccinated 
(95%CI) 
Unadjusted 
Odds Ratios 
Adjusted for 
distal 
determinants 
Adjusted for 
distal & 
intermediate 
determinants 
Adjusted for 
distal, 
intermediate & 
proximal 
determinants 
(final model) 
Final model 
adjusted for 
mediating 
effects of infant 
illness 
Final model; 
among infants 
born in a 
health facility 
      OR (95%CI) 
(p-value) 
AOR (95%CI) 
(p-value) 
AOR (95%CI) 
(p-value) 
AOR (95%CI) 
(p-value) 
AOR (95%CI) 
(p-value) 
AOR (95%CI) 
(p-value) 
Distal Variables         
Religion of head of household 
Christian 
Muslim 
None/Traditional/Other 
 
3387/15508 
1310/5310 
392/1399 
 
21.8 (21.2-22.5) 
24.7 (23.5-25.8) 
28.0 (25.7-30.4) 
 
Ref 
1.17 (1.09-1.26) 
1.39 (1.23-1.58) 
(<0.0001) 
 
Ref 
1.04 (0.95-1.13) 
0.96 (0.85-1.09) 
(0.5416) 
 
Ref 
1.01 (0.93-1.10) 
0.90 (0.79-1.03) 
(0.2438) 
 
Ref 
1.01 (0.93-1.11) 
0.90 (0.79-1.03) 
(0.2445) 
 
Ref 
1.01 (0.93-1.11) 
0.90 (0.79-1.03) 
(0.2439) 
 
Ref 
1.00 (0.89-1.11) 
0.86 (0.72-1.03) 
(0.2440) 
Ethnicity 
Akan 
Non-Akan 
 
1891/10376 
3198/11841 
 
18.2 (17.5-19.0) 
27.0 (26.2-27.8) 
 
Ref 
0.60 (0.56-0.64) 
(<0.0001) 
 
Ref 
0.91 (0.84-0.99) 
(0.0320) 
 
Ref 
0.94 (0.86-1.02) 
(0.1381) 
 
Ref 
0.93 (0.86-1.02) 
(0.1112) 
 
Ref 
0.93 (0.86-1.02) 
(0.1099) 
 
Ref 
0.96 (0.87-1.06) 
(0.4092) 
Socioeconomic status 
1 (poorest) 
2 
3 
4 
5 (richest) 
 
1618/4325 
1271/4376 
1020/4433 
709/4519 
471/4564 
 
37.4 (36.0-38.9) 
29.0 (27.7-30.4) 
23.0 (21.8-24.3) 
15.7 (14.7-16.8) 
10.3 (9.5-11.2) 
 
5.19 (4.63-5.82) 
3.56 (3.17-3.99) 
2.60 (2.31-2.92) 
1.62 (1.43-1.83) 
Ref 
(<0.0001) 
 
3.90 (3.42-4.44) 
2.91 (2.57-3.29) 
2.27 (2.01-2.57) 
1.50 (1.32-1.70) 
Ref 
(<0.0001) 
 
2.70 (2.35-3.10) 
2.33 (2.05-2.65) 
1.98 (1.75-2.24) 
1.42 (1.25-1.61) 
Ref 
(<0.0001) 
 
2.69 (2.34-3.08) 
2.32 (2.04-2.64) 
1.98 (1.74-2.24) 
1.41 (1.24-1.60) 
Ref 
(<0.0001) 
 
2.68 (2.33-3.08) 
2.32 (2.04-2.64) 
1.98 (1.74-2.24) 
1.41 (1.24-1.60) 
Ref 
(<0.0001)* 
 
2.98 (2.53-3.50) 
2.34 (2.03-2.71) 
1.98 (1.72-2.26) 
1.47 (1.28-1.68) 
Ref 
(<0.0001) 
Maternal occupation 
Gov/Private/Other 
Self-employed 
Farming 
Does not work 
 
158/1194 
1500/8714 
2082/6420 
1349/5889 
 
13.2 (11.4-15.3) 
17.2 (16.4-18.0) 
32.4 (31.3-33.6) 
22.9 (21.9-24.0) 
 
0.73 (0.61-0.87) 
Ref 
2.31 (2.14-2.49) 
1.43 (1.32-1.55) 
(<0.0001) 
 
0.89 (0.75-1.07) 
Ref 
1.33 (1.22-1.46) 
1.19 (1.09-1.30) 
(<0.0001) 
 
0.92 (0.76-1.10) 
Ref 
1.21 (1.11-1.33) 
1.13 (1.03-1.24) 
(0.0001) 
 
0.91 (0.76-1.09) 
Ref 
1.21 (1.11-1.33) 
1.13 (1.03-1.24) 
(0.0001) 
 
0.91 (0.76-1.10) 
Ref 
1.21 (1.11-1.33) 
1.13 (1.03-1.24) 
(0.0001) 
 
0.92 (0.75-1.12) 
Ref 
1.24 (1.11-1.39) 
1.18 (1.06-1.32) 
(0.0001) 
Maternal education 
None 
Primary school 
Secondary / tertiary 
 
2032/6863 
1057/4098 
2000/11256 
 
29.6 (28.5-30.7) 
25.8 (24.5-27.2) 
17.8 (17.1-18.5) 
 
1.95 (1.81-2.09) 
1.61 (1.48-1.75) 
Ref 
(<0.0001) 
 
1.13 (1.03-1.24) 
1.18 (1.08-1.29) 
Ref 
(0.0013) 
 
1.15 (1.05-1.26) 
1.17 (1.07-1.28) 
Ref 
(0.0013) 
 
1.15 (1.05-1.27) 
1.17 (1.06-1.28) 
Ref 
(0.0015) 
 
1.15 (1.05-1.27) 
1.17 (1.06-1.28) 
Ref 
(0.0015) 
 
1.13 (1.01-1.27) 
1.17 (1.05-1.31) 
Ref 
0.0138 
Vaccine due in wet season 
Yes 
No 
 
3272/14494 
1817/7723 
 
22.6 (21.9-23.3) 
23.5 (22.6-24.5) 
 
Ref 
1.06 (0.99-1.13) 
(0.1082) 
 
Ref 
1.04 (0.97-1.11) 
(0.2274) 
 
Ref 
1.04 (0.97-1.12) 
(0.2284) 
 
Ref 
1.04 (0.97-1.12) 
(0.2353) 
 
Ref 
1.04 (0.97-1.12) 
(0.2402) 
 
Ref 
1.05 (0.97-1.15) 
0.2121 
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Sex 
Male 
Female 
 
2701/11251 
2388/10966 
 
24.0 (23.2-24.8) 
21.8 (21.0-22.6) 
 
Ref 
0.88 (0.83-0.94) 
(0.0001) 
 
Ref 
0.87 (0.82-0,93) 
(<0.0001) 
 
Ref 
0.86 (0.80-0.92) 
(<0.0001) 
 
Ref 
0.85 (0.80-0.91) 
(<0.0001) 
 
Ref 
0.85 (0.80-0.91) 
(<0.0001) 
 
Ref 
0.83 (0.77-0.90) 
(<0.0001) 
Intermediate Variables         
Maternal age / Family size 
<20 years 
20-29; 1-3 children 
20-29; ≥4 children 
≥30; 1-3 children 
≥30; ≥4 children 
 
650/2531 
1601/7815 
1008/3843 
173/1108 
1657/6920 
 
25.7 (24.0-27.4) 
20.5 (19.6-21.4) 
26.2 (24.9-27.6) 
15.6 (13.6-17.9) 
23.9 (23.0-25.0) 
 
1.10 (98.8-1.22) 
0.82 (0.76-0.88) 
1.13 (1.03-1.24) 
0.59 (0.50-0.70) 
Ref 
(<0.0001) 
  
1.22 (1.07-1.39) 
1.10 (1.01-1.20) 
1.11 (1.01-1.22) 
0.93 (0.77-1.11) 
Ref 
(0.0080) 
 
1.19 (1.04-1.35) 
1.09 (1.00-1.19) 
1.11 (1.10-1.22) 
0.92 (0.76-1.10) 
Ref 
(0.0186) 
 
1.19 (1.04-1.35) 
1.09 (1.00-1.19) 
1.11 (1.01-1.22) 
0.92 (0.76-1.10) 
Ref 
(0.0191) 
 
1.27 (1.09-1.48) 
1.09 (0.98-1.22) 
1.14 (1.01-1.29) 
0.97 (0.78-1.19) 
Ref 
(0.0194) 
Maternal illness in year 
before delivery 
No 
Yes 
 
4840/21126 
249/1091 
 
22.9 (22.3-23.5) 
22.8 (20.4-25.4) 
 
Ref 
1.00 (0.86-1.15) 
(0.9468) 
  
Ref 
0.94 (0.80-1.09) 
(0.3866) 
 
Ref 
0.93 (0.80-1.08) 
(0.3568) 
 
Ref 
0.93 (0.80-1.08) 
(0.3545) 
 
Ref 
0.92 (0.76-1.11) 
(0.3764) 
Distance from health facility 
<1.00km 
1.00-4.99km 
>=5.00km 
 
2570/13471 
1146/5133 
1373/3613 
 
19.1 (18.4-19.8) 
22.3 (21.2-23.5) 
38.0 (36.4-39.6) 
 
Ref 
1.22 (1.13-1.32) 
2.60 (2.40-2.82) 
(<0.0001) 
  
Ref 
1.06 (0.98-1.16) 
1.37 (1.25-1.50) 
(<0.0001) 
 
Ref 
1.06 (0.98-1.15) 
1.37 (1.25-1.49) 
(<0.0001) 
 
Ref 
1.06 (0.98-1.15) 
1.37 (1.25-1.49) 
(<0.0001) 
 
Ref 
1.06 (0.96-1.17) 
1.60 (1.41-1.81) 
(<0.0001) 
Place of birth 
Facility 
Non-facility 
 
3079/17064 
2010/5153 
 
18.0 (17.5-18.6) 
39.0 (37.7-40.3) 
 
Ref 
2.90 (2.71-3.11) 
(<0.0001) 
  
Ref 
1.83 (1.69-1.98) 
(<0.0001) 
 
Ref 
1.82 (1.69-1.98) 
(<0.0001) 
 
Ref 
1.83 (1.69-1.98) 
(<0.0001) 
 
 
Multiple birth 
No 
Yes 
 
4898/21422 
191/795 
 
22.9 (22.3-23.4) 
24.0 (21.2-27.1) 
 
Ref 
1.07 (0.90-1.26) 
(0.4468) 
  
Ref 
1.08 (0.91-1.29) 
(0.3692) 
 
Ref 
0.93 (0.78-1.13) 
(0.4742) 
 
Ref 
0.93 (0.78-1.13) 
(0.4747) 
 
Ref 
1.00 (0.81-1.23) 
(0.9889) 
Proximal Variables         
Birth weight 
>=2.5kg 
2.00-2.49kg 
1.50-1.99kg 
<1.50kg 
 
4204/18841 
737/2910 
116/385 
32/81 
 
22.3 (21.7-22.9) 
25.3 (23.8-26.9) 
30.1 (25.7-34.9) 
39.5 (29.4-50.6) 
 
Ref 
1.18 (1.08-1.29) 
1.50 (1.20-1.87) 
2.27 (1.45-3.55) 
(<0.0001) 
   
Ref 
1.08 (0.98-1.19) 
1.64 (1.30-2.08) 
2.41 (1.50-3.88) 
(<0.0001) 
 
Ref 
1.08 (0.98-1.19) 
1.64 (1.30-2.08) 
2.42 (1.51-3.89) 
(<0.0001)* 
 
Ref 
1.12 (0.99-1.27) 
1.69 (1.28-2.22) 
2.29 (1.35-3.90 
(0.0001) 
Mediating Variable         
Neonatal illness 
No 
Yes 
 
5009/21791 
80/426 
 
23.0 (22.4-23.5) 
18.8 (15.3-22.8) 
 
Ref 
0.77 (0.61-0.99) 
(0.0363) 
    
Ref 
0.91 (0.71-1.17) 
(0.4627) 
 
Ref 
0.89 (0.66-1.20) 
(0.4542) 
* p-trend = <0.0001 
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Not being born in a health facility (compared to being born in a health facility), living 
5km or more from the nearest health facility (compared to living within 1km of a health 
facility), and being in the lowest quintile of socioeconomic status (SES) (compared to the 
highest) were all strongly associated with not receiving BCG in the neonatal period 
(Table 2). Almost 40% of home-born infants were BCG unvaccinated, and their odds of 
non-vaccination were 1.82 times those of facility-born infants (AOR=1.82; 95%CI:1.69-
1.98; p=<0.0001). Infants living >5km from a health facility had odds of non-vaccination 
1.37 those of infants living within 1km (AOR=1.37; 95%CI:1.25-1.49; p=<0.0001), even 
after adjusting for place of birth and other factors. A strong dose response relationship 
was observed between SES and neonatal BCG vaccination (p-trend <0.0001), with 
infants from the poorest quintile of SES having odds of non-vaccination 2.7 times 
greater than those from the wealthiest quintile (AOR=2.69; 95%CI:2.34-3.08) even after 
adjustment for all other explanatory variables.  
 
Being a farmer or unemployed (compared to being self-employed), having primary 
school education or no education (compared to secondary/tertiary education) and being 
aged less than 20 years of age (compared to being aged 30 or more with four or more 
children) were associated with an increased odds of non-vaccination in the final model. 
Conversely, female infants had lower odds of non-vaccination(Table 2).  
 
There was little variation in the effect size for the distal factors, after adjustment for 
intermediate and proximal mediating variables, and in the effect size for intermediate 
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level factors after adjustment for birth weight. Illness did not appear to mediate the 
effect of birth weight or any other determinants of vaccination (Table 2).  
There was little evidence that either place of delivery or infant illness modified the 
association between birth weight and vaccination (p-value for interaction all >0.2). 
 
Additional analyses of the vaccination of facility-born infants 
As a post-hoc analysis we further explored the vaccination of facility-born infants. We 
analysed their age at vaccination, and analysed their determinants of vaccination.   
 
Facility-born infants were vaccinated at a median age of 6 days (IQR=17). The effect 
estimates for the determinants of vaccination were very similar to those for the entire 
study population. The most important effect was for infants living >5km from a health 
facility, (AOR=1.60; 95%CI:1.41-1.81) (Table 2). 
 
Impact of vaccinating all facility-born infants before discharge 
Overall BCG uptake was 77.1% (95%CI:76.5-77.6) by the end of the neonatal period, 
91.8% (95%CI:91.4-92.1) by 8 weeks of age; 95.9% (95%CI:95.6-96.1) by 12 weeks of 
age, and 98.7% (95%CI:98.5-98.8) by 52 weeks of age (Table 3). At each of these time 
points, uptake declined with decreasing birth weight, although there was little 
difference at age 52 weeks (Table 3). We calculated that 91.0% (95%CI:90.6-91.3) of all 
infants, 91.2% (95%CI:87.9-93.6) of infants weighing 1.50-1.99kg, and 88.9% 
(95%CI:79.9-94.1) of infants weighing <1.50kg may have been vaccinated in the neonatal 
 17 
 
period if all facility-born infants were vaccinated prior to discharge. This represented a 
respective 18%, 31% and 47% increase in vaccine uptake by the end of the neonatal 
period. Similar smaller gains in vaccine uptake would have occurred for the other 
categories of birth weight (Table 3).  
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Table 3: BCG uptake rates at 4, 8, 12 and 52 weeks of age by birth weight, and rates that could 
be achieved if all those born in a facility had been vaccinated prior to discharge from the facility. 
BCG Uptake Rates  
Birth weight Actual Theoretical % Increase in Vaccine Uptake 
 Age 4 weeks 
>=2.5kg 
2.00-2.49kg 
1.50-1.99kg 
<1.50kg 
77.7 (77.1-78.3) 
74.7 (73.1-76.2) 
69.9 (65.1-74.3) 
60.5 (49.4-70.6) 
91.2 (90.8-91.6) 
89.4 (88.2-90.5) 
91.2 (87.9-93.6) 
88.9 (79.9-94.1) 
17.4 
19.7 
30.5 
46.9 
Overall 77.1 (76.5-77.6) 91.0 (90.6-91.3) 18.0 
 Age 8 weeks 
>=2.5kg 
2.00-2.49kg 
1.50-1.99kg 
<1.50kg 
92.1 (91.7-92.5) 
90.4 (89.3-91.4) 
87.5 (83.8-90.5) 
72.8 (62.1-81.4) 
96.7 (96.4-96.9) 
95.7 (94.9-96.4) 
97.9 (95.9-99.0) 
91.4 (82.9-95.8) 
5.0 
5.9 
11.9 
25.5 
Overall 91.8 (91.4-92.1) 96.5 (96.3-96.8) 5.1 
 Age 12 weeks 
>=2.5kg 
2.00-2.49kg 
1.50-1.99kg 
<1.50kg 
96.1 (95.8-96.4) 
95.1 (94.2-95.8) 
93.8 (90.9-95.8) 
88.9 (79.9-94.1) 
98.2 (98.1-98.4) 
97.8 (97.2-98.2) 
98.4 (96.6-99.3) 
97.5 (90.6-99.4) 
2.2 
2.8 
4.9 
9.7 
Overall 95.9 (95.6-96.1) 98.2 (98.0-98.4) 2.4 
 Age 52 weeks 
>=2.5kg 
2.00-2.49kg 
1.50-1.99kg 
<1.50kg 
98.8 (98.6-98.9) 
98.1 (97.5-98.5) 
97.4 (95.2-98.6) 
96.3 (89.1-98.8) 
99.5 (99.4-99.6) 
99.1 (98.7-99.4) 
99.5 (97.9-99.9) 
98.8 (91.7-99.8) 
0.1 
1.0 
2.2 
2.6 
Overall 98.7 (98.5-98.8) 99.4 (99.3-99.5) 0.7 
 
DISCUSSION  
Our analyses indicate that LBW infants are at high risk of missing BCG vaccination in the 
neonatal period. There appears to be a dose-response relationship between vaccination 
and birth weight; vaccination declines with decreasing birth weight, regardless of place 
of birth.  
 
We excluded sicker weaker infants who were unable to feed at enrolment, as well as 
those who died during the neonatal period. The LBW infants included in our analyses 
were probably well, and illness was probably not a contraindication to vaccination. Our 
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finding that neonatal illness did not appear to mediate the association between birth 
weight and vaccination, overall or when stratified by place of delivery, supports this. 
LBW is not a contraindication to vaccination, and LBW infants are recommended to be 
vaccinated at the same chronological age as NLBW infants;15 however, our results 
indicate that this recommendation is not being optimally adhered to in Ghana.  
 
We identified a number of additional determinants of neonatal BCG vaccination, 
including place of delivery, distance to health facility, SES, and maternal education, 
occupation and age. These were also identified as determinants in our analyses of 
postneonatal vaccination,5 and other analyses,16 and reflect broader inequities in access 
to care in our study population.  
 
In our study area, > 20% of the 77% of facility-born infants were unvaccinated at the end 
of the neonatal period, demonstrating a lack of compliance with the routine schedule. 
This was double for infants weighing <1.5kg at birth.  
 
Vaccination was even lower among home-born infants, suggesting parental delay in 
accessing vaccination services, or for those living far from a facility, the monthly 
scheduling of mobile outreach clinics. The fact that home-born LBW infants are even 
more delayed may reflect parental reluctance to bring fragile infants for vaccination, as 
previously documented in a review of unpublished surveys.6  
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Facility-born infants were vaccinated at a median age of six days, suggesting that many 
are unvaccinated at discharge following delivery; they may instead be referred to the 
child health clinic for vaccination. This would explain why birth weight and other 
maternal and household factors remain as vaccine determinants among facility-born 
infants. If true, then this practice is allowing inequities in vaccination to persist. A single 
vial of BCG vaccinates twenty infants. Fear of wastage has previously been cited as a 
reason for missing opportunities for vaccination,17 and may be a motivation for referring 
facility-born infants to the child health clinic for vaccination.  
 
Overall uptake of BCG vaccination at age 52 weeks was high; however, many infants 
were vaccinated late, including a higher proportion of LBW infants. BCG vaccination is 
known to have an important protective effect against TB meningitis in the first five years 
of life18. Timely vaccination is important so as not to prolong the risk of infection. 
Furthermore, timeliness of vaccination is increasingly recognised as an important 
indicator of the overall quality of vaccination programmes19, and our finding that LBW 
infants were less likely to be in compliance with the routine schedule, highlights them as 
a group who are underserved by vaccination. The Global Vaccine Action Plan2 advocates 
for identifying groups who are underserved by routine vaccination services so that they 
can be targeted for vaccination, and so that inequities in the delivery of the vaccination 
programme can be reduced. Ensuring vaccination of facility-born infants prior to 
discharge would optimise compliance with the recommended schedule and the 
timeliness of BCG vaccination.  
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Our finding of reduced vaccination of LBW infants is consistent with our previous finding 
of delayed postneonatal vaccination (with DTP1 and DTP3) of LBW infants.5. It also 
supports recent findings20 from Nairobi Kenya, that infants weighing <2.00kg living in 
informal urban settlements took 9 times longer to be vaccinated in the first 90 days of 
life than NLBW infants. The difference in the magnitude of the association between our 
study and the Kenyan study may be due to the exclusion of unvaccinated infants, the 
lower prevalence of LBW (6%), the higher proportion of facility-born infants (96%), and 
the higher proportion of private facility-born infants (67%) in the Kenyan study. 
 
Data from Guinea Bissau21 also suggested lower BCG vaccination among LBW infants. As 
there was reportedly a national policy of delaying vaccination of LBW infants until they 
had gained weight or attended for DTP vaccination, these results are not generalisable 
to countries, such as Ghana, where no such policy exists.   
 
A study from Nigeria22 reported delayed vaccination of under-nourished children. This 
study provides indirect evidence of the effect of birth weight, in addition to infant 
feeding and illness (the causes of undernourishment23) on BCG vaccination.  
 
Strengths 
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Our study was strengthened by low loss to follow-up rates (<3%), by the population-
based nature of the sample and by the collection of high quality data on both birth 
weight and vaccination.  
 
Limitations 
We lacked qualitative data on the practices associated with vaccination following 
delivery, including the reasons why infants born in health facilities were not getting 
vaccinated, and why LBW infants born in health facilities were less likely to be 
vaccinated. This limits our understanding of the barriers to neonatal vaccination (among 
both facility-born and home-born infants), and to the vaccination of LBW infants.  
A large number of variables were included in our models, thus increasing the possibility 
of type-1 errors. Due to small numbers, our study was underpowered to detect 
differences in analyses where birth weight was stratified by factors such as infant illness. 
Although we demonstrated that vaccinating all facility-born infants prior to discharge 
could substantively improve the timing and equity of delivery of BCG vaccination, this 
finding may not be generalizable to settings where most infants are born at home.  
 
CONCLUSIONS  
Our analyses indicate that LBW is a risk factor for not being vaccinated with BCG in the 
neonatal period, even for facility-born LBW infants. Efforts to improve neonatal 
vaccination, especially for LBW infants, are warranted, regardless of where they are 
born. For LBW infants born in facilities, vaccination prior to discharge is recommended. 
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Qualitative studies to understand the reasons for non-vaccination with BCG in the 
neonatal period are needed. In particular studies are needed to understand why infants, 
including LBW infants born in health facilities are not getting vaccinated. 
 
WHAT IS ALREADY KNOWN ON THIS TOPIC 
Delayed BCG vaccination was associated with low birth weight (LBW) among primarily 
facility born infants in urban slums in Kenya. 
Undernourishment (caused by LBW, illness and feeding practices) was also associated 
with delayed BCG vaccination in urban Nigeria. 
 
WHAT THIS STUDY ADDS 
This large, generalisable prospective population-based cohort study in rural Ghana 
demonstrates lower compliance with the BCG vaccination schedule among LBW 
compared to non-LBW infants. 
LBW is a strong determinant of neonatal BCG vaccination, with a dose response 
relationship between birth weight and vaccination. 
The association persists even for facility-born LBW infants, suggesting a lack of 
compliance with policy to vaccinate prior to discharge from the facility. 
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